PMID: 11900095Mar 20, 2002Paper

Defined-contribution health insurance products: development and prospects

Health Affairs
Jon B ChristiansonRuth Taylor

Abstract

Defined-contribution health insurance products have received considerable recent attention, stimulated by double-digit increases in health plan premiums and employers' desire to get their employees more involved in health care purchasing decisions. Existing products typically feature a consumer health spending account, a major medical or other insurance policy, and the use of the Internet to support consumer decision making. They vary in their use of provider networks, provider payment approaches, the specific design of spending accounts, marketing strategies, and infrastructure investment. The companies producing these products are now at a critical juncture. They could grow rapidly over the next few years, be acquired by existing health plans, or fail if they do not deliver on their promises.

Citations

Jan 24, 2003·The New England Journal of Medicine·Antonio Legorreta
Sep 20, 2002·The New England Journal of Medicine·John K Iglehart
Mar 19, 2005·Health Research Policy and Systems·Ronald LagoeGert P Westert
Sep 7, 2004·Nursing Management·Vivette S Walker
Apr 23, 2005·Administration and Policy in Mental Health·Mardi ColemanJay Himmelstein
Aug 1, 2002·Expert Review of Pharmacoeconomics & Outcomes Research·William E Encinosa
Jul 3, 2004·Health Services Research·Stephen T ParenteJon B Christianson
Jul 3, 2004·Health Services Research·Jon B ChristiansonRoger Feldman
Jul 3, 2004·Health Services Research·Jinnet Briggs FowlesJohn Bertko
Jul 3, 2004·Health Services Research·Stephen T ParenteJon B Christianson
Aug 18, 2004·Health Policy·Raisa B DeberLeslie L Roos
Mar 26, 2003·Health Services Research·Jon B Christianson, Sally Trude
Sep 22, 2016·The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care·Hao Yu
Nov 14, 2006·Medical Care Research and Review : MCRR·Lynn A BlewettTimothy J Beebe
Sep 18, 2004·Medical Care Research and Review : MCRR·Douglas A Conrad, Jon B Christianson
Nov 15, 2005·Health Affairs·James C Robinson
Nov 15, 2005·Health Affairs·Roger FeldmanRuth Taylor
May 11, 2006·Health Affairs·Lydia RegopoulosSally Trude
Apr 22, 2003·Health Affairs·Jason S Lee, Laura Tollen
Aug 1, 2008·Expert Review of Pharmacoeconomics & Outcomes Research·Stephen T Parente, Roger Feldman
Sep 13, 2002·Health Affairs·J Lee Hargraves, Sally Trude

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.